메뉴 건너뛰기




Volumn 350, Issue , 2015, Pages

Quantifying and monitoring overdiagnosis in cancer screening: A systematic review of methods

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER OVERDIAGNOSIS; CANCER SCREENING; COHORT ANALYSIS; COLORECTAL CANCER; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DISEASE MODEL; EVIDENCE BASED PRACTICE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERNAL VALIDITY; KIDNEY CANCER; LUNG CANCER; MELANOMA; METHODOLOGY; MONITORING; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RELIABILITY; RISK OF BIAS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; THYROID CANCER; UTERUS CANCER; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; MASS SCREENING; NEOPLASMS; OBSERVATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; TIME;

EID: 84921328480     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g7773     Document Type: Article
Times cited : (156)

References (67)
  • 1
    • 0034674903 scopus 로고    scopus 로고
    • Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening
    • Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000;92:1280-2.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 1280-1282
    • Black, W.C.1
  • 3
    • 84873050929 scopus 로고    scopus 로고
    • Women's views on overdiagnosis in breast cancer screening: A qualitative study
    • Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ 2013;346:f158.
    • (2013) BMJ , vol.346 , pp. f158
    • Hersch, J.1    Jansen, J.2    Barratt, A.3    Irwig, L.4    Houssami, N.5    Howard, K.6
  • 4
    • 0033666081 scopus 로고    scopus 로고
    • US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: Cross-sectional survey
    • Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey. West J Med 2000;173:307.
    • (2000) West J Med , vol.173 , pp. 307
    • Schwartz, L.M.1    Woloshin, S.2    Sox, H.C.3    Fischhoff, B.4    Welch, H.G.5
  • 7
    • 80052670271 scopus 로고    scopus 로고
    • Breast cancer screening for women ages 50 to 69 years: A systematic review of observational evidence
    • Harris R, Yeatts J, Kinsinger L. Breast cancer screening for women ages 50 to 69 years: a systematic review of observational evidence. Prev Med 2011;53:108-14.
    • (2011) Prev Med , vol.53 , pp. 108-114
    • Harris, R.1    Yeatts, J.2    Kinsinger, L.3
  • 8
    • 84921422273 scopus 로고    scopus 로고
    • US Preventive Services Task Force Procedure Manual
    • 08-05118-EF
    • US Preventive Services Task Force Procedure Manual. AHRQ publication no. 08-05118-EF. 2008. www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm.
    • (2008) AHRQ Publication
  • 9
    • 77949609822 scopus 로고    scopus 로고
    • Grading the strength of a body of evidence when comparing medical interventions-agency for healthcare research and quality and the effective health care program
    • Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. Grading the strength of a body of evidence when comparing medical interventions-agency for healthcare research and quality and the effective health care program. J Clin Epidemiol 2010;63:513-23.
    • (2010) J Clin Epidemiol , vol.63 , pp. 513-523
    • Owens, D.K.1    Lohr, K.N.2    Atkins, D.3    Treadwell, J.R.4    Reston, J.T.5    Bass, E.B.6
  • 10
    • 69149107727 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration
    • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94.
    • (2009) Ann Intern Med , vol.151 , pp. W65-W94
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3    Mulrow, C.4    Gøtzsche, P.C.5    Ioannidis, J.P.A.6
  • 11
    • 16644373262 scopus 로고    scopus 로고
    • Overdiagnosis in early detection programs
    • Davidov O, Zelen M. Overdiagnosis in early detection programs. Biostatistics 2004;5:603-13.
    • (2004) Biostatistics , vol.5 , pp. 603-613
    • Davidov, O.1    Zelen, M.2
  • 12
    • 64949135826 scopus 로고    scopus 로고
    • Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context
    • Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulat R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009;101:374-83.
    • (2009) J Natl Cancer Inst , vol.101 , pp. 374-383
    • Draisma, G.1    Etzioni, R.2    Tsodikov, A.3    Mariotto, A.4    Wever, E.5    Gulat, R.6
  • 13
    • 84873364644 scopus 로고    scopus 로고
    • Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: Model estimates of potential benefits and harms
    • Gulati R, Gore JL, Etzioni R. Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms. Ann Intern Med 2013;158:145-53.
    • (2013) Ann Intern Med , vol.158 , pp. 145-153
    • Gulati, R.1    Gore, J.L.2    Etzioni, R.3
  • 14
    • 84893845633 scopus 로고    scopus 로고
    • Individualized estimates of overdiagnosis in screen-detected prostate cancer
    • Gulati R, Inoue LY, Gore JL, Katcher J, Etzioni R. Individualized estimates of overdiagnosis in screen-detected prostate cancer. J Natl Cancer Inst 2014;106:djt367.
    • (2014) J Natl Cancer Inst , vol.106 , pp. djt367
    • Gulati, R.1    Inoue, L.Y.2    Gore, J.L.3    Katcher, J.4    Etzioni, R.5
  • 16
    • 0032409148 scopus 로고    scopus 로고
    • Screening for prostate cancer: Estimating the magnitude of overdetection
    • McGregor M, Hanley JA, Boivin JF, McLean RG. Screening for prostate cancer: estimating the magnitude of overdetection. Can Med Assoc J 1998;159:1368-72.
    • (1998) Can Med Assoc J , vol.159 , pp. 1368-1372
    • McGregor, M.1    Hanley, J.A.2    Boivin, J.F.3    McLean, R.G.4
  • 17
    • 63949088395 scopus 로고    scopus 로고
    • Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: Implications of sojourn time on screening
    • Pashayan N, Duffy SW, Pharoah P, Greenberg D, Donovan J, Martin RM, et al. Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening. Br J Cancer 2009;100:1198-204.
    • (2009) Br J Cancer , vol.100 , pp. 1198-1204
    • Pashayan, N.1    Duffy, S.W.2    Pharoah, P.3    Greenberg, D.4    Donovan, J.5    Martin, R.M.6
  • 18
    • 39849100398 scopus 로고    scopus 로고
    • Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends
    • Telesca D, Etzioni R, Gulati R. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Biometrics 2008;64:10-9.
    • (2008) Biometrics , vol.64 , pp. 10-19
    • Telesca, D.1    Etzioni, R.2    Gulati, R.3
  • 19
    • 33746903130 scopus 로고    scopus 로고
    • A population model of prostate cancer incidence
    • Tsodikov A, Szabo A, Wegelin J. A population model of prostate cancer incidence. Stat Med 2006;25:2846-66.
    • (2006) Stat Med , vol.25 , pp. 2846-2866
    • Tsodikov, A.1    Szabo, A.2    Wegelin, J.3
  • 20
    • 84864126860 scopus 로고    scopus 로고
    • Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening
    • Wu GHM, Auvinen A, Maattanen L, Tammela TLJ, Stenman UH, Hakama M, et al. Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening. Int J Cancer 2012;131:1367-75.
    • (2012) Int J Cancer , vol.131 , pp. 1367-1375
    • Wu, G.H.M.1    Auvinen, A.2    Maattanen, L.3    Tammela, T.L.J.4    Stenman, U.H.5    Hakama, M.6
  • 23
    • 29244451535 scopus 로고    scopus 로고
    • Estimates of overdiagnosis from two trials of mammographic screening for breast cancer
    • Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, et al. Estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005;7:258-65.
    • (2005) Breast Cancer Res , vol.7 , pp. 258-265
    • Duffy, S.W.1    Agbaje, O.2    Tabar, L.3    Vitak, B.4    Bjurstam, N.5    Björneld, L.6
  • 24
    • 84870053696 scopus 로고    scopus 로고
    • Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom
    • Gunsoy NB, Garcia-Closas M, Moss SM. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom. Breast Cancer Res 2012;14:R152.
    • (2012) Breast Cancer Res , vol.14 , pp. R152
    • Gunsoy, N.B.1    Garcia-Closas, M.2    Moss, S.M.3
  • 27
    • 84859009639 scopus 로고    scopus 로고
    • Overdiagnosis from non-progressive cancer detected by screening mammography: Stochastic simulation study with calibration to population based registry data
    • Seigneurin A, Francois O, Labarere J, Oudeville P, Monlong J, Colonna M. Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data. BMJ 2011;343:d7017.
    • (2011) BMJ , vol.343 , pp. d7017
    • Seigneurin, A.1    Francois, O.2    Labarere, J.3    Oudeville, P.4    Monlong, J.5    Colonna, M.6
  • 28
    • 84897572716 scopus 로고    scopus 로고
    • Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom
    • Duffy SW, Field JK, Allgood PC, Seigneurin A. Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer 2014;110:1834-40.
    • (2014) Br J Cancer , vol.110 , pp. 1834-1840
    • Duffy, S.W.1    Field, J.K.2    Allgood, P.C.3    Seigneurin, A.4
  • 29
    • 84864743952 scopus 로고    scopus 로고
    • Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers
    • Hazelton WD, Goodman G, Rom WN, Tockman M, Thornquist M, Moolgavkar S, et al. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers. Math Biosci 2012;240:20-34.
    • (2012) Math Biosci , vol.240 , pp. 20-34
    • Hazelton, W.D.1    Goodman, G.2    Rom, W.N.3    Tockman, M.4    Thornquist, M.5    Moolgavkar, S.6
  • 30
    • 1642286684 scopus 로고    scopus 로고
    • An early- and late-stage convolution model for disease natural history
    • Pinsky PF. An early- and late-stage convolution model for disease natural history. Biometrics 2004;60:191-8.
    • (2004) Biometrics , vol.60 , pp. 191-198
    • Pinsky, P.F.1
  • 31
    • 84855841165 scopus 로고    scopus 로고
    • Evaluating the long-term effect of FOBT in colorectal cancer screening
    • Luo D, Cambon AC, Wu D. Evaluating the long-term effect of FOBT in colorectal cancer screening. Cancer Epidemiol 2012;36:e54-60.
    • (2012) Cancer Epidemiol , vol.36 , pp. e54-e60
    • Luo, D.1    Cambon, A.C.2    Wu, D.3
  • 32
    • 84885182193 scopus 로고    scopus 로고
    • Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis
    • Zahl PH, Jorgensen KJ, Gotzsche PC. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer 2013;109:2014-9.
    • (2013) Br J Cancer , vol.109 , pp. 2014-2019
    • Zahl, P.H.1    Jorgensen, K.J.2    Gotzsche, P.C.3
  • 33
    • 84855773344 scopus 로고    scopus 로고
    • A population-based cohort study of chest x-ray screening in smokers: Lung cancer detection findings and follow-up
    • Dominioni L, Rotolo N, Mantovani W, Poli A, PIsani S, Conti V, et al. A population-based cohort study of chest x-ray screening in smokers: Lung cancer detection findings and follow-up. BMC Cancer 2012;12:18.
    • (2012) BMC Cancer , vol.12 , pp. 18
    • Dominioni, L.1    Rotolo, N.2    Mantovani, W.3    Poli, A.4    Pisani, S.5    Conti, V.6
  • 34
    • 33846408647 scopus 로고    scopus 로고
    • Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers
    • Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;242:555-62.
    • (2007) Radiology , vol.242 , pp. 555-562
    • Lindell, R.M.1    Hartman, T.E.2    Swensen, S.J.3    Jett, J.R.4    Midthun, D.E.5    Tazelaar, H.D.6
  • 35
    • 0026534052 scopus 로고
    • Survival for clinical stage I lung cancer not surgically treated: Comparison between screen-detected and symptom-detected cases
    • Sobue T, Suzuki T, Matsuda M, Kuroishi T, Ikeda S, Naruke T. Survival for clinical stage I lung cancer not surgically treated: comparison between screen-detected and symptom-detected cases. Cancer 1992;69:685-92.
    • (1992) Cancer , vol.69 , pp. 685-692
    • Sobue, T.1    Suzuki, T.2    Matsuda, M.3    Kuroishi, T.4    Ikeda, S.5    Naruke, T.6
  • 36
    • 35748948079 scopus 로고    scopus 로고
    • Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography
    • Sone S, Nakayama T, Honda T, Tsushima K, Li F, Haniuda M, et al. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 2007;58:329-41.
    • (2007) Lung Cancer , vol.58 , pp. 329-341
    • Sone, S.1    Nakayama, T.2    Honda, T.3    Tsushima, K.4    Li, F.5    Haniuda, M.6
  • 37
    • 84870525789 scopus 로고    scopus 로고
    • Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: A cohort study
    • Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2012;157:776-84.
    • (2012) Ann Intern Med , vol.157 , pp. 776-784
    • Veronesi, G.1    Maisonneuve, P.2    Bellomi, M.3    Rampinelli, C.4    Durli, I.5    Bertolotti, R.6
  • 40
    • 44849126959 scopus 로고    scopus 로고
    • Clinical and pathological features of screen vs non-screen-detected prostate cancers: Is there a difference?
    • Pelzer AE, Colleselli D, Bektic J, Schaefer G, Ongarello S, Schwentner C, et al. Clinical and pathological features of screen vs non-screen-detected prostate cancers: is there a difference? BJU Int 2008;102:24-7.
    • (2008) BJU Int , vol.102 , pp. 24-27
    • Pelzer, A.E.1    Colleselli, D.2    Bektic, J.3    Schaefer, G.4    Ongarello, S.5    Schwentner, C.6
  • 41
    • 84869451873 scopus 로고    scopus 로고
    • Effect of three decades of screening mammography on breast-cancer incidence
    • Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. New Engl J Med 2012;367:1998-2005.
    • (2012) New Engl J Med , vol.367 , pp. 1998-2005
    • Bleyer, A.1    Welch, H.G.2
  • 42
    • 84880001115 scopus 로고    scopus 로고
    • Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program
    • Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. CMAJ 2013;185:E492-8.
    • (2013) CMAJ , vol.185 , pp. E492-E498
    • Coldman, A.1    Phillips, N.2
  • 43
    • 77950673205 scopus 로고    scopus 로고
    • Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
    • Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25-30.
    • (2010) J Med Screen , vol.17 , pp. 25-30
    • Duffy, S.W.1    Tabar, L.2    Olsen, A.H.3    Vitak, B.4    Allgood, P.C.5    Chen, T.H.H.6
  • 44
    • 84875621036 scopus 로고    scopus 로고
    • Overdiagnosis among women attending a population-based mammography screening program
    • Falk RS, Hofvind S, Skaane P, Haldorsen T. Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer 2013;133:705-12.
    • (2013) Int J Cancer , vol.133 , pp. 705-712
    • Falk, R.S.1    Hofvind, S.2    Skaane, P.3    Haldorsen, T.4
  • 45
    • 84860612151 scopus 로고    scopus 로고
    • Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden
    • Hellquist BN, Duffy SW, Nystrom L, Jonsson H. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden. J Med Screen 2012;19:14-9
    • (2012) J Med Screen , vol.19 , pp. 14-19
    • Hellquist, B.N.1    Duffy, S.W.2    Nystrom, L.3    Jonsson, H.4
  • 46
    • 68149122164 scopus 로고    scopus 로고
    • Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends
    • Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
    • (2009) BMJ , vol.339 , pp. b2587
    • Jørgensen, K.J.1    Gøtzsche, P.C.2
  • 47
    • 74549138493 scopus 로고    scopus 로고
    • Overdiagnosis in organised mammography screening in Denmark. A comparative study
    • Jorgensen KJ, Zahl PH, Gotzsche PC. Overdiagnosis in organised mammography screening in Denmark. a comparative study. BMC Women's Health 2009;9:36.
    • (2009) BMC Women's Health , vol.9 , pp. 36
    • Jorgensen, K.J.1    Zahl, P.H.2    Gotzsche, P.C.3
  • 48
    • 80053175037 scopus 로고    scopus 로고
    • An investigation of the apparent breast cancer epidemic in France: Screening and incidence trends in birth cohorts
    • Junod B, Zahl PH, Kaplan RM, Olsen J, Greenland S. An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer 2011;11:401.
    • (2011) BMC Cancer , vol.11 , pp. 401
    • Junod, B.1    Zahl, P.H.2    Kaplan, R.M.3    Olsen, J.4    Greenland, S.5
  • 49
    • 84864814977 scopus 로고    scopus 로고
    • Overdiagnosis of invasive breast cancer due to mammography screening
    • Kalager M, Adami H, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med 2012;157:221-2.
    • (2012) Ann Intern Med , vol.157 , pp. 221-222
    • Kalager, M.1    Adami, H.2    Bretthauer, M.3    Tamimi, R.M.4
  • 51
    • 84875795617 scopus 로고    scopus 로고
    • Overdiagnosis in screening mammography in Denmark: Population based cohort study
    • Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E. Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ 2013;346:f1064.
    • (2013) BMJ , vol.346 , pp. f1064
    • Njor, S.H.1    Olsen, A.H.2    Blichert-Toft, M.3    Schwartz, W.4    Vejborg, I.5    Lynge, E.6
  • 52
    • 34247550789 scopus 로고    scopus 로고
    • Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy
    • Paci E, Miccinesi G, Puliti D, Baldazzi P, De Lisi V, Falcini F, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res 2006;8:R68.
    • (2006) Breast Cancer Res , vol.8 , pp. R68
    • Paci, E.1    Miccinesi, G.2    Puliti, D.3    Baldazzi, P.4    De Lisi, V.5    Falcini, F.6
  • 53
    • 0024383636 scopus 로고
    • Evaluation of overdiagnosis of breast cancer in screening with mammography: Results of the Nijmegen programmme
    • Peeters PHM, Verbeek ALM, Straatman H, Holland R, Hendriks JHCL, Mravunac M, et al. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programmme. Int J Epidemiol 1989;18:295-9.
    • (1989) Int J Epidemiol , vol.18 , pp. 295-299
    • Peeters, P.H.M.1    Verbeek, A.L.M.2    Straatman, H.3    Holland, R.4    Jhcl, H.5    Mravunac, M.6
  • 54
    • 70450189063 scopus 로고    scopus 로고
    • An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence
    • Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45:3166-71.
    • (2009) Eur J Cancer , vol.45 , pp. 3166-3171
    • Puliti, D.1    Zappa, M.2    Miccinesi, G.3    Falini, P.4    Crocetti, E.5    Paci, E.6
  • 56
    • 33646366677 scopus 로고    scopus 로고
    • Breast cancer incidence after the introduction of mammography screening: What should be expected?
    • Svendsen AL, Olsen AH, Von Euler-Chelpin M, Lynge E. Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 2006;106:1883-90.
    • (2006) Cancer , vol.106 , pp. 1883-1890
    • Svendsen, A.L.1    Olsen, A.H.2    Von Euler-Chelpin, M.3    Lynge, E.4
  • 57
    • 1942542421 scopus 로고    scopus 로고
    • Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study
    • Zahl PH, Strand BH, Maeshlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921-4.
    • (2004) BMJ , vol.328 , pp. 921-924
    • Zahl, P.H.1    Strand, B.H.2    Maeshlen, J.3
  • 58
    • 84860204639 scopus 로고    scopus 로고
    • Overdiagnosis of breast cancer after 14 years of mammography screening
    • Zahl PH, Maehlen J. Overdiagnosis of breast cancer after 14 years of mammography screening. Tidsskr Nor Legeforen 2012;132:414-7.
    • (2012) Tidsskr Nor Legeforen , vol.132 , pp. 414-417
    • Zahl, P.H.1    Maehlen, J.2
  • 59
    • 13244283284 scopus 로고    scopus 로고
    • Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994)
    • Ciatto S, Gervasi G, Bonardi R, Frullini P, Zendron P, Lombardi C, et al. Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994). Eur J Cancer 2005;41:411-5.
    • (2005) Eur J Cancer , vol.41 , pp. 411-415
    • Ciatto, S.1    Gervasi, G.2    Bonardi, R.3    Frullini, P.4    Zendron, P.5    Lombardi, C.6
  • 60
    • 0032442585 scopus 로고    scopus 로고
    • Overdiagnosis of prostate carcinoma by screening: An estimate based on the results of the Florence screening pilot study
    • Zappa M. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence screening pilot study. Ann Oncol 1998;9:1297-300.
    • (1998) Ann Oncol , vol.9 , pp. 1297-1300
    • Zappa, M.1
  • 61
    • 33645513485 scopus 로고    scopus 로고
    • Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: Follow-up study
    • Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006;332:689-91.
    • (2006) BMJ , vol.332 , pp. 689-691
    • Zackrisson, S.1    Andersson, I.2    Janzon, L.3    Manjer, J.4    Garne, J.P.5
  • 63
    • 84896690485 scopus 로고    scopus 로고
    • Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomised screening trial
    • Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366.
    • (2014) BMJ , vol.348 , pp. g366
    • Miller, A.B.1    Wall, C.2    Baines, C.J.3    Sun, P.4    To, T.5    Narod, S.A.6
  • 64
    • 33645501981 scopus 로고    scopus 로고
    • Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers
    • Welch HG, Schwartz LM, Woloshin S. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers. BMJ 2006;332:727.
    • (2006) BMJ , vol.332 , pp. 727
    • Welch, H.G.1    Schwartz, L.M.2    Woloshin, S.3
  • 65
    • 36549040026 scopus 로고    scopus 로고
    • Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: A systematic review
    • Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8:1129-38.
    • (2007) Lancet Oncol , vol.8 , pp. 1129-1138
    • Biesheuvel, C.1    Barratt, A.2    Howard, K.3    Houssami, N.4    Irwig, L.5
  • 66
    • 84868112192 scopus 로고    scopus 로고
    • Overdiagnosis in mammographic screening for breast cancer in Europe: A literature review
    • Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012;19(suppl 1):42-56.
    • (2012) J Med Screen , vol.19 , pp. 42-56
    • Puliti, D.1    Duffy, S.W.2    Miccinesi, G.3    De Koning, H.4    Lynge, E.5    Zappa, M.6
  • 67
    • 84878716848 scopus 로고    scopus 로고
    • Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening
    • Etzioni R, Gulati R, Mallinger L, Mandelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med 2013;158:831-8.
    • (2013) Ann Intern Med , vol.158 , pp. 831-838
    • Etzioni, R.1    Gulati, R.2    Mallinger, L.3    Mandelblatt, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.